REDUCED PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF REPAGLINIDE: IMPACT OF OATP1B1 AND CYP2C8 GENOTYPE ON THE PREDICTION OF DDI RISK | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

HERO ID

3223831

Reference Type

Journal Article

Title

REDUCED PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF REPAGLINIDE: IMPACT OF OATP1B1 AND CYP2C8 GENOTYPE ON THE PREDICTION OF DDI RISK

Author(s)

Gertz, M; Tsamandouras, N; Aarons, L; Galetin, A

Year

2014

Is Peer Reviewed?

Yes

Journal

Clinical Pharmacology & Therapeutics
ISSN: 0009-9236
EISSN: 1532-6535

Volume

Page Numbers

S96-S96

Web of Science Id

WOS:000332009800281